Alimera Sciences Inc Extends Gains On FDA News By: Benzinga via Benzinga September 29, 2014 at 10:59 AM EDT Alimera Sciences Inc (NASDAQ: ALIM) extended its gains Monday after the company's treatment for diabetes-related vision loss won ... Read More >> Related Stocks: Alimera Sciences Inc